Maxi-Torque Plus Angiographic Catheter
510(k) K955111
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK955111 | Date31 Jan 1996 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DQO
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.1200
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 21 Sep 2026
An intravascular diagnostic catheter is a device used to record intracardiac pressures, to sample blood, and to introduce substances into the heart and vessels. Included in this generic device are right-heart catheters, left-heart catheters, and angiographic catheters, among others.
The device is a Class 2 Cardiovascular device with product code DQO cleared through the Traditional 510(k) pathway after an 84-day FDA review. It received FDA 510(k) clearance K955111 on January 31, 1996, from Adam Spence Corp.
Other devices from Adam Spencer Corp.
Questions
AI-generated answers, 21 Sep 2026
What is the MAXI-TORQUE PLUS ANGIOGRAPHIC CATHETER used for?
The MAXI-TORQUE PLUS ANGIOGRAPHIC CATHETER is an intravascular diagnostic catheter used to record intracardiac pressures, sample blood, and introduce substances into the heart and vessels, including for right-heart and left-heart catheterization and angiographic procedures.
Who manufactures the MAXI-TORQUE PLUS ANGIOGRAPHIC CATHETER and where are they located?
The MAXI-TORQUE PLUS ANGIOGRAPHIC CATHETER is manufactured by Adam Spence Corp., located at 19526 E. Lake Dr., Miami, FL 33015, United States, as indicated in the device authorization records.
What regulatory pathway was used to clear the MAXI-TORQUE PLUS ANGIOGRAPHIC CATHETER and when was it cleared?
The MAXI-TORQUE PLUS ANGIOGRAPHIC CATHETER was cleared through the Traditional 510(k) pathway after an 84-day FDA review, receiving FDA 510(k) clearance K955111 on January 31, 1996, based on a determination of substantial equivalence.